Simon V. van Reijmersdal

2.5k total citations
25 papers, 1.1k citations indexed

About

Simon V. van Reijmersdal is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Hematology. According to data from OpenAlex, Simon V. van Reijmersdal has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Public Health, Environmental and Occupational Health, 11 papers in Molecular Biology and 10 papers in Hematology. Recurrent topics in Simon V. van Reijmersdal's work include Acute Lymphoblastic Leukemia research (12 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Cancer-related gene regulation (6 papers). Simon V. van Reijmersdal is often cited by papers focused on Acute Lymphoblastic Leukemia research (12 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Cancer-related gene regulation (6 papers). Simon V. van Reijmersdal collaborates with scholars based in Netherlands, United States and Germany. Simon V. van Reijmersdal's co-authors include Ad Geurts van Kessel, Roland P. Kuiper, Peter M. Hoogerbrugge, Esmé Waanders, Frank N. van Leeuwen, Joris A. Veltman, Eric Schoenmakers, Rolph Pfundt, Willy M. Nillesen and M.A.R. Leisink and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Simon V. van Reijmersdal

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simon V. van Reijmersdal Netherlands	11	434	395	363	323	297	25	1.1k
Elena Kolomietz Canada	11	269 0.6×	114 0.3×	305 0.8×	168 0.5×	225 0.8×	23	734
Elisabeth T Korthof Netherlands	13	153 0.4×	260 0.7×	383 1.1×	605 1.9×	194 0.7×	18	1.1k
AD Auerbach United States	9	244 0.6×	165 0.4×	730 2.0×	328 1.0×	60 0.2×	10	1.0k
Barbara Adler‐Brecher United States	7	163 0.4×	111 0.3×	462 1.3×	197 0.6×	67 0.2×	9	677
Nataline B. Kardon United States	13	329 0.8×	103 0.3×	232 0.6×	85 0.3×	281 0.9×	26	640
Shunsuke Kimura Japan	13	144 0.3×	83 0.2×	203 0.6×	95 0.3×	67 0.2×	40	476
Michel Zwaan Netherlands	8	87 0.2×	263 0.7×	320 0.9×	335 1.0×	67 0.2×	19	715
OA Haas Austria	15	66 0.2×	369 0.9×	407 1.1×	656 2.0×	76 0.3×	18	904
C. R. Bartram Germany	11	60 0.1×	412 1.0×	183 0.5×	357 1.1×	142 0.5×	17	696
Hagen Graf Einsiedel Germany	7	44 0.1×	237 0.6×	233 0.6×	195 0.6×	98 0.3×	13	548

Countries citing papers authored by Simon V. van Reijmersdal

Since Specialization

Citations

This map shows the geographic impact of Simon V. van Reijmersdal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon V. van Reijmersdal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon V. van Reijmersdal more than expected).

Fields of papers citing papers by Simon V. van Reijmersdal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon V. van Reijmersdal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon V. van Reijmersdal. The network helps show where Simon V. van Reijmersdal may publish in the future.

Co-authorship network of co-authors of Simon V. van Reijmersdal

This figure shows the co-authorship network connecting the top 25 collaborators of Simon V. van Reijmersdal. A scholar is included among the top collaborators of Simon V. van Reijmersdal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon V. van Reijmersdal. Simon V. van Reijmersdal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smits, Willem K., Carlo Vermeulen, Shunsuke Kimura, et al.. (2023). Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemia. Cell Reports. 42(4). 112373–112373. 5 indexed citations

Simons, Annet, Janneke Schuurs-Hoeijmakers, Evelien Zonneveld‐Huijssoon, et al.. (2022). Trio-based whole exome sequencing in patients with suspected sporadic inborn errors of immunity: A retrospective cohort study. eLife. 11. 4 indexed citations

Solanich, Xavier, Gardenia Vargas‐Parra, Caspar I. van der Made, et al.. (2021). Genetic Screening for TLR7 Variants in Young and Previously Healthy Men With Severe COVID-19. Frontiers in Immunology. 12. 719115–719115. 74 indexed citations

Yu, Jiangyan, Esmé Waanders, Simon V. van Reijmersdal, et al.. (2020). Upfront Treatment Influences the Composition of Genetic Alterations in Relapsed Pediatric B‐Cell Precursor Acute Lymphoblastic Leukemia. HemaSphere. 4(1). e318–e318. 5 indexed citations

Antić, Željko, Jiangyan Yu, Simon V. van Reijmersdal, et al.. (2020). Multiclonal complexity of pediatric acute lymphoblastic leukemia and the prognostic relevance of subclonal mutations. Haematologica. 106(12). 3046–3055. 14 indexed citations

Yu, Jiangyan, Željko Antić, Simon V. van Reijmersdal, et al.. (2017). Accurate detection of low-level mosaic mutations in pediatric acute lymphoblastic leukemia using single molecule tagging and deep-sequencing. Leukemia & lymphoma. 59(7). 1690–1699. 5 indexed citations

Waanders, Esmé, Blanca Scheijen, Marjolijn C.J. Jongmans, et al.. (2016). Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrences. Leukemia. 31(4). 821–828. 38 indexed citations

Kuiper, Roland P., Simon V. van Reijmersdal, Marieke Simonis, et al.. (2015). Targeted Locus Amplification & Next Generation Sequencing for the Detection of Recurrent and Novel Gene Fusions for Improved Treatment Decisions in Pediatric Acute Lymphoblastic Leukemia. Blood. 126(23). 696–696. 3 indexed citations

Hoogerbrugge, Peter M., Esmé Waanders, Simon V. van Reijmersdal, et al.. (2014). Correlation of childhood acute lymphoblastic leukemia subclones carrying intragenic IKZF1 deletions with relapse.. Journal of Clinical Oncology. 32(15_suppl). 10043–10043. 1 indexed citations

10.

Krumbholz, Manuela, Agata Pastorczak, Blanca Scheijen, et al.. (2014). DNA copy number alterations mark disease progression in paediatric chronic myeloid leukaemia. British Journal of Haematology. 166(2). 250–253. 8 indexed citations

11.

Yu, Jiangyan, Esmé Waanders, Simon V. van Reijmersdal, et al.. (2014). The Majority of RAS Pathway Mutations Detected in Relapsed B-Cell Precursor Acute Lymphoblastic Leukemia Are Present in Major or Minor Subclones at Diagnosis. Blood. 124(21). 2397–2397. 1 indexed citations

12.

Veer, Arian van der, Esmé Waanders, Rob Pieters, et al.. (2013). Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL. Blood. 122(15). 2622–2629. 187 indexed citations

13.

Waanders, Esmé, Blanca Scheijen, Laurens T. van der Meer, et al.. (2012). The Origin and Nature of Tightly Clustered BTG1 Deletions in Precursor B-Cell Acute Lymphoblastic Leukemia Support a Model of Multiclonal Evolution. PLoS Genetics. 8(2). e1002533–e1002533. 59 indexed citations

14.

Toonen, Erik J. M., Christian Gilissen, Barbara Franke, et al.. (2012). Validation Study of Existing Gene Expression Signatures for Anti-TNF Treatment in Patients with Rheumatoid Arthritis. PLoS ONE. 7(3). e33199–e33199. 49 indexed citations

15.

Waanders, Esmé, Vincent H. J. van der Velden, C. Ellen van der Schoot, et al.. (2010). Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia. Leukemia. 25(2). 254–258. 91 indexed citations

16.

Waanders, Esmé, C. Ellen van der Schoot, Frank N. van Leeuwen, et al.. (2010). Integrated Use of Minimal Residual Disease Classification and IKZF1 Alteration Status Accurately Predicts 79% of Relapses In Pediatric Acute Lymphoblastic Leukemia. Blood. 116(21). 272–272. 9 indexed citations

17.

Schraders, Margit, Simon V. van Reijmersdal, Eveline J. Kamping, et al.. (2009). High-resolution genomic profiling of pediatric lymphoblastic lymphomas reveals subtle differences with pediatric acute lymphoblastic leukemias in the B-lineage. Cancer Genetics and Cytogenetics. 191(1). 27–33. 23 indexed citations

18.

Leeuwen, Frank N. van, Joost C. van Galen, Roland P. Kuiper, et al.. (2009). BTG1, a Gene Frequently Deleted in Pre-B ALL, Controls Glucocorticoid Receptor-Mediated Gene Expression.. Blood. 114(22). 3458–3458. 1 indexed citations

19.

Kuiper, Roland P., Esmé Waanders, Vincent H. J. van der Velden, et al.. (2009). Deletion of IKZF1 in Pediatric Precursor-B ALL Is a Strong Prognostic Marker for Relapse.. Blood. 114(22). 1104–1104. 1 indexed citations

20.

Vries, Bert B.A. de, Rolph Pfundt, M.A.R. Leisink, et al.. (2005). Diagnostic Genome Profiling in Mental Retardation. The American Journal of Human Genetics. 77(4). 606–616. 413 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact